Last reviewed · How we verify
Oral tablet and transdermal patch — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Oral tablet and transdermal patch (Oral tablet and transdermal patch) — B.P. Koirala Institute of Health Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oral tablet and transdermal patch TARGET | Oral tablet and transdermal patch | B.P. Koirala Institute of Health Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oral tablet and transdermal patch CI watch — RSS
- Oral tablet and transdermal patch CI watch — Atom
- Oral tablet and transdermal patch CI watch — JSON
- Oral tablet and transdermal patch alone — RSS
Cite this brief
Drug Landscape (2026). Oral tablet and transdermal patch — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-tablet-and-transdermal-patch. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing